|
LGR4 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.780270E-03 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.822100E-02 |
| Normal-vs-Stage2 |
2.377400E-03 |
| Normal-vs-Stage3 |
3.79700000000538E-05 |
| Normal-vs-Stage4 |
2.158200E-03 |
| Stage1-vs-Stage2 |
1.381020E-01 |
| Stage1-vs-Stage3 |
8.380300E-03 |
| Stage1-vs-Stage4 |
1.574180E-01 |
| Stage2-vs-Stage3 |
8.201200E-01 |
| Stage2-vs-Stage4 |
9.214800E-01 |
| Stage3-vs-Stage4 |
7.170200E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.368400E-04 |
| Normal-vs-AfricanAmerican |
5.322400E-01 |
| Normal-vs-Asian |
9.551200E-01 |
| Caucasian-vs-AfricanAmerican |
8.056500E-02 |
| Caucasian-vs-Asian |
1.022300E-02 |
| AfricanAmerican-vs-Asian |
6.349400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.987000E-04 |
| Normal-vs-Female |
6.040100E-03 |
| Male-vs-Female |
1.814040E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.130300E-02 |
| Normal-vs-Age(41-60Yrs) |
3.144800E-03 |
| Normal-vs-Age(61-80Yrs) |
1.63726999999891E-05 |
| Normal-vs-Age(81-100Yrs) |
6.264300E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.734600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.343900E-03 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.039200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.899800E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.706620E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.338800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
3.015900E-02 |
| Classical-VS-Follicular |
6.583100E-03 |
| Classical-VS-Other |
7.759200E-01 |
| Classical-VS-Normal |
2.698200E-02 |
| Tall-VS-Follicular |
7.487600E-01 |
| Tall-VS-Other |
6.931200E-01 |
| Tall-VS-Normal |
7.644700E-04 |
| Follicular-VS-Other |
5.617800E-01 |
| Follicular-VS-Normal |
2.627900E-04 |
| Other-VS-Normal |
2.589800E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.009700E-04 |
| Normal-vs-N1 |
5.996500E-02 |
| N0-vs-N1 |
2.692600E-01 |
|
|
